Similar articles

• R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.

  Verver E, Pecci A, De Rocco D, Ryhänen S, Barozzi S, Kunst H, Topsakal V, Savoia A. Verver E, et al. Clin Genet. 2015 Jul;88(1):85-9. doi: 10.1111/cge.12438. Epub 2014 Jul 26. Clin Genet. 2015. PMID: 24890873
• Cochlear implants for DFNA17 deafness.

  Hildebrand MS, de Silva MG, Gardner RJ, Rose E, de Graaf CA, Bahlo M, Dahl HH. Hildebrand MS, et al. Laryngoscope. 2006 Dec;116(12):2211-5. doi: 10.1097/01.mlg.0000242089.72880.f8. Laryngoscope. 2006. PMID: 17146397
• Progressive hereditary hearing impairment caused by a MYO6 mutation resembles presbyacusis.

  Oonk AM, Leijendeckers JM, Lammers EM, Weegerink NJ, Oostrik J, Beynon AJ, Huygen PL, Kunst HP, Kremer H, Snik AF, Pennings RJ. Oonk AM, et al. Hear Res. 2013 May;299:88-98. doi: 10.1016/j.heares.2012.12.015. Epub 2013 Jan 20. Hear Res. 2013. PMID: 23340379
• Clinical presentation of the DFNA loci where causative genes have not yet been cloned. DFNA4, DFNA6/14, DFNA7, DFNA16, DFNA20 and DFNA21.

  Huygen PL, Bom SJ, Van Camp G, Cremers CW. Huygen PL, et al. Adv Otorhinolaryngol. 2002;61:98-106. doi: 10.1159/000066820. Adv Otorhinolaryngol. 2002. PMID: 12408070 Review. No abstract available.
• [Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy].

  Ptok M. Ptok M. HNO. 2000 Jan;48(1):28-32. doi: 10.1007/s001060050005. HNO. 2000. PMID: 10663046 Review. German.